What the FDA says
- Compounded drugs are not FDA-approved.
- The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed.
- The agency has warned about products marketed as weight-loss GLP-1s that are not approved products.
How the two differ on paper
| Attribute | FDA-approved product | Compounded preparation |
|---|---|---|
| Pre-market FDA review | Yes | No |
| Manufacturer-published pricing | Commonly published | Set by the compounder or program |
| Listed in Drugs@FDA | Yes | No |
| Manufacturer savings programs | May apply | Do not apply |
Questions to ask a program before paying
- 1.Is the product you would dispense FDA-approved, or compounded?
- 2.If compounded, which pharmacy prepares it and under what state licence?
- 3.What exactly am I paying for each month, and does the price change if the product changes?
- 4.What happens to my payments if the program stops offering this product?
Truvela does not prescribe, dispense or provide medical advice. We publish what things cost, where the numbers come from, and when we checked.
Frequently asked questions
- Are compounded GLP-1 drugs FDA-approved?
- No. The FDA states that compounded drugs are not FDA-approved and do not undergo FDA pre-market review for safety, effectiveness or quality.
- Why are compounded versions sometimes cheaper?
- They are priced by the compounder or the program rather than by a manufacturer's published self-pay price, and they are outside manufacturer savings programs. Price differences do not indicate equivalence.
- How do I check whether a product is FDA-approved?
- Search the product name in the FDA's Drugs@FDA database, which lists approved drug products.
Sources
Every figure above traces to one of these published sources.
- 1. U.S. Food & Drug Administration — Compounded semaglutide and tirzepatide: FDA's concerns (FDA, verified 2026-08-18)
- 2. U.S. Food & Drug Administration — Drugs@FDA — approved drug products database (FDA, verified 2026-08-18)